1. Home
  2. MRNA vs OC Comparison

MRNA vs OC Comparison

Compare MRNA & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • OC
  • Stock Information
  • Founded
  • MRNA 2010
  • OC 1938
  • Country
  • MRNA United States
  • OC United States
  • Employees
  • MRNA N/A
  • OC N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • OC Industrial Machinery/Components
  • Sector
  • MRNA Health Care
  • OC Industrials
  • Exchange
  • MRNA Nasdaq
  • OC Nasdaq
  • Market Cap
  • MRNA 16.5B
  • OC 16.9B
  • IPO Year
  • MRNA 2018
  • OC N/A
  • Fundamental
  • Price
  • MRNA $38.36
  • OC $174.38
  • Analyst Decision
  • MRNA Hold
  • OC Buy
  • Analyst Count
  • MRNA 19
  • OC 13
  • Target Price
  • MRNA $79.50
  • OC $200.83
  • AVG Volume (30 Days)
  • MRNA 7.7M
  • OC 782.8K
  • Earning Date
  • MRNA 11-07-2024
  • OC 02-12-2025
  • Dividend Yield
  • MRNA N/A
  • OC 1.58%
  • EPS Growth
  • MRNA N/A
  • OC N/A
  • EPS
  • MRNA N/A
  • OC 11.72
  • Revenue
  • MRNA $5,081,000,000.00
  • OC $10,439,000,000.00
  • Revenue This Year
  • MRNA N/A
  • OC $16.55
  • Revenue Next Year
  • MRNA N/A
  • OC $8.90
  • P/E Ratio
  • MRNA N/A
  • OC $14.89
  • Revenue Growth
  • MRNA N/A
  • OC 8.09
  • 52 Week Low
  • MRNA $35.80
  • OC $138.70
  • 52 Week High
  • MRNA $170.47
  • OC $214.53
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 35.63
  • OC 27.50
  • Support Level
  • MRNA $41.06
  • OC $194.80
  • Resistance Level
  • MRNA $44.38
  • OC $202.15
  • Average True Range (ATR)
  • MRNA 2.57
  • OC 4.58
  • MACD
  • MRNA 0.16
  • OC -3.46
  • Stochastic Oscillator
  • MRNA 1.74
  • OC 0.64

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About OC Owens Corning Inc New

Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with three reportable segments: Composites, Insulation, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: